BrainStorm appoints Kirk Taylor as Chief Medical Officer

BrainStorm appointed Kirk Taylor as Executive VP and Chief Medical Officer, effective May 1. BrainStorm Cell prepares for regulatory review of the company’s Biologics License Application for NurOwn for the treatment of amyotrophic lateral sclerosis. Taylor is joining BrainStorm from EMD Serono, where, as Senior VP, North American Medical Affairs, he led the medical team’s efforts across four therapeutic areas and the launch of three new treatments. Prior to EMD Serono, Taylor served as Senior VP, Medical Affairs Strategy and Operations at Verastem Oncology and CMO and Chief of Strategy and Late Phase Development at Finch Therapeutics Group.